Preliminary unaudited revenue for the full year 2022 is expected to be between $489 million and $490 million, an increase of 106% to 107% compared to the full year 2021. Full year 2022 U.S. Coronary preliminary unaudited revenue is expected to be between $288 million and $289 million
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SWAV:
- Shockwave Medical Announces Agreement to Acquire Neovasc
- Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
- ShockWave selloff presents buying opportunity, says Piper Sandler
- Cardiovascular Systems initiated with an Equal Weight at Barclays
- Wells Fargo cuts ShockWave Medical to Equal Weight, sees growth runway priced in